Infections pose numerous challenges to healthcare systems and contribute to higher morbidity, mortality and significantly increasing costs. While clinicians need to make rapid treatment decisions, often they rely on empirical use of antibiotics without knowing the causative pathogen or whether it is characterized as drug-susceptible or drug-resistant; consequently, leading to increasing antimicrobial resistance (AMR) and multi-drug resistance (MDR).
Technology platforms and solutions that simplify and facilitate detection of drug-resistant infections will continue to evolve and provide value in the fight against AMR. As more healthcare systems adopt platforms that deliver treatment insights to enable smarter use of antibiotics, we can expect to see an uptick in cloud-based solutions that encourage collaboration between healthcare facilities and providers.
OpGen’s cloud-based data management platforms provide the capability to identify, track, and predict antibiotic-resistant infections based on genetic information.* MapIt has the potential to bring together OpGen’s bioinformatics gene sequence analysis solutions – Acuitas Lighthouse knowledge base and AI-powered AMR prediction combining ARESdb with NGS to help guide care and enhance targeted antibiotic decision making.